SRDX - Surmodics, Inc.
IEX Last Trade
39.62
-0.050 -0.126%
Share volume: 181,065
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$39.67
-0.05
-0.13%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2022-11-23 | 2023-02-06 | 2023-04-26 | 2023-08-02 | 2023-11-22 | 2024-02-01 | 2024-05-01 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 158.359 M | 169.755 M | 166.163 M | 188.901 M | 185.733 M | 180.240 M | 182.805 M | 177.413 M | |
| Current Assets | 57.587 M | 64.462 M | 61.244 M | 85.850 M | 86.691 M | 79.808 M | 84.263 M | 80.356 M | |
| Inventories | 11.819 M | 12.724 M | 13.767 M | 14.610 M | 14.839 M | 14.438 M | 15.405 M | 15.405 M | |
| Other Current Assets | 13.880 M | 15.119 M | 16.177 M | 14.909 M | 15.159 M | 16.916 M | 14.854 M | 13.386 M | |
| Short Term Investments | 13.880 M | 15.119 M | 16.177 M | 14.909 M | 15.159 M | 16.916 M | 14.854 M | 13.386 M | |
| Total Receivables | 12.890 M | 10.189 M | 12.120 M | 11.752 M | 11.341 M | 13.280 M | 13.065 M | 13.390 M | |
| Current Cash | 18.998 M | 26.430 M | 19.180 M | 44.579 M | 45.352 M | 35.174 M | 40.939 M | 38.175 M | |
| Total Non-current Assets | 100.772 M | 105.293 M | 104.919 M | 103.051 M | 99.042 M | 100.432 M | 98.542 M | 97.057 M | |
| Property Plant Equipment | 27.148 M | 27.717 M | 27.614 M | 26.571 M | 26.026 M | 25.563 M | 25.718 M | 25.319 M | |
| Other Assets | 1.136 M | 1.526 M | 1.437 M | 1.683 M | 877.000 K | 724.000 K | 4.464 M | 1.448 M | |
| Intangible Assets | 28.145 M | 29.262 M | 28.726 M | 27.798 M | 26.206 M | 26.213 M | 24.784 M | 23.702 M | |
| Goodwill | 40.710 M | 43.308 M | 43.823 M | 43.844 M | 42.946 M | 44.283 M | 43.576 M | 43.355 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 158.359 M | 169.755 M | 166.163 M | 188.901 M | 185.733 M | 180.240 M | 182.805 M | 177.413 M | |
| Total liabilities | 49.967 M | 62.494 M | 63.609 M | 76.489 M | 65.823 M | 58.090 M | 58.855 M | 59.269 M | |
| Total current liabilities | 32.079 M | 17.264 M | 19.130 M | 32.048 M | 23.954 M | 16.477 M | 19.197 M | 20.196 M | |
| Accounts Payable | 3.136 M | 2.035 M | 3.788 M | 2.484 M | 2.993 M | 2.581 M | 3.186 M | 3.186 M | |
| Other liabilities | 12.018 M | 10.049 M | 9.834 M | 9.971 M | 7.486 M | 6.742 M | 5.141 M | 4.870 M | |
| Current long term debt | 10.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 29.495 M | 29.303 M | 29.353 M | 29.405 M | 29.443 M | 29.480 M | 29.517 M | |
| Other liabilities | 12.018 M | 10.049 M | 9.834 M | 9.971 M | 7.486 M | 6.742 M | 5.141 M | 4.870 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 108.392 M | 107.261 M | 102.554 M | 112.412 M | 119.910 M | 122.150 M | 123.950 M | 118.144 M | |
| Common stock | 13.940 M | 13.983 M | 14.030 M | 14.050 M | 14.061 M | 14.102 M | 14.152 M | 14.170 M | |
| Retained earnings | 88.791 M | 80.948 M | 73.215 M | 80.561 M | 87.255 M | 86.469 M | 86.716 M | 79.162 M |